Abbonarsi

Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease - 23/05/13

Doi : 10.1016/j.ahj.2013.03.001 
Jeffrey L. Carson, MD a, , Maria Mori Brooks, PhD b, J. Dawn Abbott, MD c, Bernard Chaitman, MD d, Sheryl F. Kelsey, PhD b, Darrell J. Triulzi, MD e, Vankeepuram Srinivas, MD f, Mark A. Menegus, MD f, Oscar C. Marroquin, MD g, Sunil V. Rao, MD h, Helaine Noveck, MPH a, Elizabeth Passano, MS b, Regina M. Hardison, MS b, Thomas Smitherman, MD g, Tudor Vagaonescu, MD i, Neil J. Wimmer, MD j, David O. Williams, MD j
a Division of General Internal Medicine, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ 
b Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 
c Division of Cardiology, Rhode Island Hospital, Alpert Medical School, Brown University, Providence, RI 
d Department of Medicine, Saint Louis University, Saint Louis, MO 
e Institute for Transfusion Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 
f Division of Cardiology, Albert Einstein College of Medicine, New York, NY 
g Division of Cardiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 
h Duke Clinical Research Institute, Duke University, Durham, NC 
i Division of Cardiology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ 
j Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 

Reprint requests: Jeffrey L. Carson, MD, Division of General Internal Medicine, Robert Wood Johnson Medical School, New Brunswick, NJ.

Riassunto

Background

Prior trials suggest it is safe to defer transfusion at hemoglobin levels above 7 to 8 g/dL in most patients. Patients with acute coronary syndrome may benefit from higher hemoglobin levels.

Methods

We performed a pilot trial in 110 patients with acute coronary syndrome or stable angina undergoing cardiac catheterization and a hemoglobin <10 g/dL. Patients in the liberal transfusion strategy received one or more units of blood to raise the hemoglobin level ≥10 g/dL. Patients in the restrictive transfusion strategy were permitted to receive blood for symptoms from anemia or for a hemoglobin <8 g/dL. The predefined primary outcome was the composite of death, myocardial infarction, or unscheduled revascularization 30 days post randomization.

Results

Baseline characteristics were similar between groups except age (liberal, 67.3; restrictive, 74.3). The mean number of units transfused was 1.6 in the liberal group and 0.6 in the restrictive group. The primary outcome occurred in 6 patients (10.9%) in the liberal group and 14 (25.5%) in the restrictive group (risk difference = 15.0%; 95% confidence interval of difference 0.7% to 29.3%; P = .054 and adjusted for age P = .076). Death at 30 days was less frequent in liberal group (n = 1, 1.8%) compared to restrictive group (n = 7, 13.0%; P = .032).

Conclusions

The liberal transfusion strategy was associated with a trend for fewer major cardiac events and deaths than a more restrictive strategy. These results support the feasibility of and the need for a definitive trial.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 T. Bruce Ferguson, Jr, MD, served as guest editor for this article.
 RCT reg #NCT01167582.


© 2013  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 165 - N° 6

P. 964 - giugno 2013 Ritorno al numero
Articolo precedente Articolo precedente
  • Left ventricular mechanical dyssynchrony by cardiac magnetic resonance is greater in patients with strict vs nonstrict electrocardiogram criteria for left bundle-branch block
  • Linus G. Andersson, Katherine C. Wu, Björn Wieslander, Zak Loring, Terry F. Frank, Charles Maynard, Gary Gerstenblith, Gordon F. Tomaselli, Robert G. Weiss, Galen S. Wagner, Martin Ugander, David G. Strauss
| Articolo seguente Articolo seguente
  • Gender differences in clinical outcomes among diabetic patients hospitalized for cardiovascular disease
  • Laura Flink, Heidi Mochari-Greenberger, Lori Mosca

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.